Cyclosporine A, a potent immunosuppressive agent, is extensively utilized in ophthalmic treatments. However, its high relative molecular mass and pronounced hydrophobicity pose challenges to its penetration through the physiological barriers of eyes, leading to low bioavailability. By strategically integrating innovative excipients and formulation technologies, the bioavailability of cyclosporine A can be enhanced from four aspects: increasing drug solubility, facilitating penetration through ocular mucus, boosting deep penetration into corneal tissues, and extending residence time on the ocular surface. This review focuses on the characteristics, action mechanisms, and associated formulation technologies of novel excipients employed in cyclosporine A ophthalmic formulations, to provide a reference for efficient delivery of cyclosporine A and the development of future novel formulations.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |